gip and glp-1 weight loss Science Behind GLP 1 Glucagon Receptor Agonists for Obesity Research | News & Announcements Nuviva Medical Weight Loss Clinics

The global GLP-1 analogues market size was calculated at USD 66.48 billion in 2025 and is predicted to increase from USD 88.58 billion in 2026 to approximately USD 1,062.90 billion by 2035, expanding at a CAGR of 31.94% from 2026 to 2035

Federal expansion is coming : New programs in 2026 may open the door to broader Medicaid GLP-1 coverage, but timelines and participation will vary by state

If hair thinning, fatigue, dry skin, constipation, or weight gain are being driven by hypothyroidism, your first priority is usually to make sure thyroid hormone replacement treatment is optimized

(N=22 older men) demonstrated that nightly subcutaneous sermorelin increased mean plasma IGF-1 by roughly 30% over 6 months [1]

Together, they tackle the two most fundamental drivers of skin aging, structural decline and oxidative damage, in a way that no topical product can fully replicate